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Late December 2019, a coronavirus disease (COVID-19) was

•

identified in Wuhan, China. COVID-19 was a result of the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which has resulted in a
worldwide sudden and substantial increase in hospitalizations for pneumonia
with multiorgan disease. As of October 6, 2020, SARS-CoV-2 has affected
more than 200 countries, resulting in more than 35 million identified cases
with more than 1 million confirmed deaths.

This is a cross-sectional, non-interventional, observational study in
patients infected with the novel coronavirus (SARS-CoV-2) or Covid-19,
using the John Hopkins University (JHU) Coronavirus database, and Institute
for Health Metrics and Evaluation (IHME) database. The data collected from
the JHU Coronavirus database and IHME database will be used to create a
MATLAB program, which will produce graphs with standardized data that
will be used to investigate, describe and compare the circumstances during
the past year in the US and the EU5 (UK, Germany, France, Italy and Spain).
The experiment compared the number of confirmed cases and confirmed
deaths because of the Covid-19 disease. Furthermore, the experiment
compared each country’s deaths from non-communicable diseases (NCDs),
smoking, and obesity. The experiment found the most important risk factors
and comorbidities associated with mortality of patients infected by COVID19.
The countries chosen were picked based on the following facts:
•

All 6 Countries are considered high-income countries

•

The EU5 have a public healthcare system versus the private healthcare
system in the US

•

All 6 countries have similar education and health literacy level

•

All 6 countries had the first COVID-19 case during January 2020

•

All 6 countries are a popular hub for travelers and tourists

•
•
•
•
•

Graph 1
US never flattened the curve, unlike European
countries between May and August 2020
US maintained the highest number of confirmed cases
per 100,000 since June 2020
Germany maintained the lowest number of confirmed
cases per 100,000 since April 2020
Number of case in Europe (except Germany) began
rising exponentially towards the end of the summer
2020
Spain and France are nearing the US’s number of
cases per 100,000 and are rising at a steeper rate
Germany didn’t rise until October, unlike other
European Countries, but still had the overall lowest
number of cases per 100,000
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•
•
•
•
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The line graphs were created using the plot function. The bar graphs were created
using the bar function. Graph titles were added using the title function. Axis labels
were added using the xlabel and ylabel functions for the x-axis and y-axis,
respectively. The size of graphs 1 and 2 had to be modified using gca or current axes.
The font was increased and bolded for graphs 3 and 4 using gcf or current graph
handle. The legends were added using the legend function. For graphs 3 and 4, the
legends had to be altered to horizontal orientation using the legend function.

All the concluding statements are only regarding the discussed
countries.
The risk factors and comorbidities found to increase the severity
and mortality of COVID-19 were as follows: Cardiovascular Disease,
Neoplasms, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus,
Chronic Kidney Disease, Obesity (>30 BMI), Smoking, and old age (65+).
In conclusion, Germany was the most successful in minimizing the
number of cases and deaths from COVID-19 per 100,000, even though the
country leads in deaths per 100,000 from 3 NCDs, second to the US in
smoking and obesity related deaths per 100,000, and 21.1% of the
population is above 65 years old. On the contrary, Spain was the least
successful in terms of the number of deaths from COVID-19 per 100,000.
The US was the least successful in controlling the spread of the virus as they
have predominantly maintained the highest number of cases of COVID-19
per 100,000.
Germany was early and efficient in beginning to prevent the spread
of the virus. “Robert Koch Institute (RKI) and scientists at other institutions
mobilized in early January to launch national crisis management to
understand the epidemiology of the pandemic.”1 Furthermore, Germany
continued in its success to detect the virus as they were one of the very first
countries to develop a diagnostic test for COVID-19 and have conducted
rigorous contact tracing. Moreover, Germany’s government worked along
public and private laboratories to maximize the potential and efficiency for
testing. Another aspect Germany was successful in, with regards to the
spread of the virus, was limiting the transmission in long-term care
establishments, which led to a significantly lower number of cases among
the older population, further lowering the case-fatality rate. Finally,
Germany has the highest number of hospital beds per 10,000 (80.0) and with
careful planning alongside educated actions, the healthcare system did not
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become overstressed, allowing
treatment for all severely
affected cases.
Spain maintained the highest number of deaths per 100,000 caused
by COVID-19 since April 2020. Spain exercised an extremely strict national
lockdown from March 14th till May 9th, 2020. Unlike its neighboring
Injured
countries
to the east, Spain has a significantly lowerIntact
number of hospital beds
per 100,000 (29.7) (France: 59.8). “The first HCW infected was confirmed
on March 9th. A total of 791 HCW and personnel were confirmed to be
infected by March 29th, representing 38% of those tested and 11,6 % of all
the hospital workers.” 2
US maintained a steady increase in the number of COVID-19 cases
per 100,000 and currently hold the highest number of cases worldwide.
Unlike its European counterparts, the US never flattened the curve.
Furthermore, the US federal government failed to devise a national strategy
to lead, direct, and support the states. Overall, the US response was
primarily on a state level only, with only a few states enacting state level
lockdowns.

Graph 2
Number of confirmed deaths per 100,000 in the US
maintained a semi-constant rate of increase from
April to November 2020
Spain predominantly maintained the highest number
of confirmed deaths per 100,000 since April 2020
Germany maintained the lowest number of
confirmed deaths per 100,000 since April
Number of deaths in Europe (except Germany)
began rising exponentially towards the end of the
summer 2020
European countries (except Germany) had a semivertical rise in confirmed deaths per 100,000
between March and April 2020

If proven successful, this project can identify some of the factors that
increase the severity and mortality of the disease among the discussed
countries, and in turn shine a light on some of the areas where healthcare
services and public education need improvement.

The responses of each country were researched and studied to isolate any key
actions that impacted the rate of spread of the virus, including, but not limited to, first
case date, number of tests per case, percent of positive tests, local and national
mandates description and dates, and contact tracing.
Prior research articles were considered and analyzed to explore and discover
the relation between COVID-19 and other factors that could significantly increase
the severity and mortality of the disease.
Data was obtained from JHU and IHME databases. The data for confirmed
cases was then imported and standardized using MATLAB through the following
mathematical equation:
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝐶𝑜𝑛𝑓𝑖𝑟𝑚𝑒𝑑 𝐶𝑎𝑠𝑒𝑠
𝑁𝐶𝐶 =
∗ 100,000
𝐶𝑜𝑢𝑛𝑡𝑟𝑦 𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛
Data for confirmed deaths, from COVID-19, and identified factors, was
standardized using a similar mathematical equation:
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝐶𝑜𝑛𝑓𝑖𝑟𝑚𝑒𝑑 𝐷𝑒𝑎𝑡ℎ𝑠
𝑁𝐶𝐷 =
∗ 100,000
𝐶𝑜𝑢𝑛𝑡𝑟𝑦 𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛
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Graph 4 (2019)
US has the highest number of deaths from smoking
per 100,000
US has a significantly higher number of deaths
caused by obesity (>30 Body Mass Index [BMI])
per 100,000
France has the lowest number of deaths per 100,000
caused by obesity
Italy has the lowest number of deaths per 100,000
caused by smoking

Germany has the highest number of deaths per 100,000
for 3 NCDs and 2nd highest number of deaths per
100,000 caused by obesity and smoking

Graph 3 (2019)
Germany has the highest number of deaths per
100,000 from Cardiovascular disease (CVD),
Neoplasms (Cancers), and Chronic Kidney disease
(CKD)
Italy has the highest number of deaths per 100,000
from Diabetes Mellitus (DM)
Spain has the highest number of deaths per 100,000
from Chronic Obstructive Pulmonary Disease
(COPD)
France has the lowest number of deaths per 100,000
from CVD and COPD
US has the lowest number of deaths per 100,000
from Neoplasms
UK has the lowest number of deaths per 100,000
from DM and CKD
•
•
•
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•
•
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